Skip to Content
Merck
CN
  • Role and regulation of coordinately expressed de novo purine biosynthetic enzymes PPAT and PAICS in lung cancer.

Role and regulation of coordinately expressed de novo purine biosynthetic enzymes PPAT and PAICS in lung cancer.

Oncotarget (2015-07-04)
Moloy T Goswami, Guoan Chen, Balabhadrapatruni V S K Chakravarthi, Satya S Pathi, Sharath K Anand, Shannon L Carskadon, Thomas J Giordano, Arul M Chinnaiyan, Dafydd G Thomas, Nallasivam Palanisamy, David G Beer, Sooryanarayana Varambally
ABSTRACT

Cancer cells exhibit altered metabolism including aerobic glycolysis that channels several glycolytic intermediates into de novo purine biosynthetic pathway. We discovered increased expression of phosphoribosyl amidotransferase (PPAT) and phosphoribosylaminoimidazole carboxylase, phosphoribosylaminoimidazole succinocarboxamide synthetase (PAICS) enzymes of de novo purine biosynthetic pathway in lung adenocarcinomas. Transcript analyses from next-generation RNA sequencing and gene expression profiling studies suggested that PPAT and PAICS can serve as prognostic biomarkers for aggressive lung adenocarcinoma. Immunohistochemical analysis of PAICS performed on tissue microarrays showed increased expression with disease progression and was significantly associated with poor prognosis. Through gene knockdown and over-expression studies we demonstrate that altering PPAT and PAICS expression modulates pyruvate kinase activity, cell proliferation and invasion. Furthermore we identified genomic amplification and aneuploidy of the divergently transcribed PPAT-PAICS genomic region in a subset of lung cancers. We also present evidence for regulation of both PPAT and PAICS and pyruvate kinase activity by L-glutamine, a co-substrate for PPAT. A glutamine antagonist, 6-Diazo-5-oxo-L-norleucine (DON) blocked glutamine mediated induction of PPAT and PAICS as well as reduced pyruvate kinase activity. In summary, this study reveals the regulatory mechanisms by which purine biosynthetic pathway enzymes PPAT and PAICS, and pyruvate kinase activity is increased and exposes an existing metabolic vulnerability in lung cancer cells that can be explored for pharmacological intervention.

MATERIALS
Product Number
Brand
Product Description

Roche
Anti-Digoxigenin-Fluorescein, Fab fragments, from sheep
Roche
Biotin-Nick Translation Mix, suitable for hybridization, solution, sufficient for 40 labeling reactions, pkg of 160 μL
Roche
DIG-Nick Translation Mix, sufficient for 40 labeling reactions, pkg of 160 μL, suitable for hybridization